Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Investing in digital could 'unlock £22bn' for UK pharma

Accenture outlines tech's revenue-growth and cost-saving potential

Digital health tech

A greater use of digital health technology such as wearables and smart packaging could help the UK pharmaceutical industry ‘unlock £22bn’ over the next decade.

That value would come from a combination of potential revenue-growth and cost-savings, according to new analysis from Accenture.

The consultants say investing in digital technologies could see the UK pharma sector accelerate growth by 5%, generating an estimated £12bn in new revenue over ten years.

Companies would also consequently be able to reduce their costs by more than £11bn and pass on cost savings of 10% direct to consumers.

In addition to wearables and tech-enabled packaging Accenture highlighted the potential of analytics-based virtual screening and sensors as technology that could also help pharma tackle its ‘long-term productivity challenge’.

Yen-Sze Soon, managing director at Accenture, said: “Most pharmaceutical companies we work with recognise that digital technologies can drive transformation and growth, but many aren’t yet realising this potential. This research quantifies the potential prize for industry, individuals and society if they get this right.

“The solution is what we call Industry X.0, an action plan for embracing and profiting from technological change. More than just transforming into digital businesses, pharma companies must look at how they reinvent operating models, production and value chains.”

The company’s ‘value at stake’ model was created by Accenture Strategy and is based on the World Economic Forum own ‘value at stake’ approach to understanding the value of digital transformation, for industry and society.

15th March 2018

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics